MedPath

Incidence of Pancreatic Fistula After Radical Gastrectomy

Conditions
Pancreatic Fistula
Complication
Gastric Cancer
Interventions
Diagnostic Test: Amylase Test
Registration Number
NCT03391687
Lead Sponsor
Shanghai Zhongshan Hospital
Brief Summary

This study is designed to investigate the incidence of pancreatic fistula after radical gastrectomy in gastric cancer patients.

Detailed Description

Pancreatic fistula, which can lead to fatal end, is one of the most serious complications after radical gastrectomy. It is usually treated as a key factor to evaluate the quality of gastrectomy. The incidence of pancreatic fistula is far different between different areas, knowing the prevalence of pancreatic fistula and risk factors can help us to prevent pancreatic fistula and improve the short time outcome of gastric cancer surgery treatment. So, we designed this perspective, multi-center study to investigate the incidence of pancreatic fistula and its outcome in China.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
2100
Inclusion Criteria
  • pathological confirmed stomach adenocarcinoma
  • preoperative curatively resectable tumor
Exclusion Criteria
  • pancreas resection
  • emergent surgery due to gastric cancer acute complications
  • cancer of gastric remnant

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Amylase TestAmylase Testgastric cancer patients receiving radical gastrectomy
Primary Outcome Measures
NameTimeMethod
Incidence of Pancreatic Fistulain 30 days following gastrectomy

the incidence of pancreatic fistula after radical gastrectomy in gastric cancer patients

Secondary Outcome Measures
NameTimeMethod
The Classification of Pancreatic Fistulain 30 days following gastrectomy

the percentage of different grades of pancreatic fistula, including Grade BL, Grade B and Grade C

The mortality of Grade B and C Pancreatic Fistulain 30 days following gastrectomy

the percentage of patients died of Grade B or C pancreatic fistula

Trial Locations

Locations (20)

Beijing Cancer Hospital

πŸ‡¨πŸ‡³

Beijing, Beijing, China

ZhongShan hospital Fudan university

πŸ‡¨πŸ‡³

Shanghai, Shanghai, China

Fujian Medical University Union Hospital

πŸ‡¨πŸ‡³

Fuzhou, Fujian, China

Beijing Chao-Yang Hospital

πŸ‡¨πŸ‡³

Beijing, Beijing, China

Henan Cancer Hospital

πŸ‡¨πŸ‡³

Zhengzhou, Henan, China

Weifang People's Hospital

πŸ‡¨πŸ‡³

Weifang, Shandong, China

South West Hospital

πŸ‡¨πŸ‡³

Chongqing, Chongqing, China

Guangdong General Hospital

πŸ‡¨πŸ‡³

Guangzhou, Guangdong, China

The First Affiliated Hospital, Sun Yat-sen University

πŸ‡¨πŸ‡³

Guangzhou, Guangdong, China

Jiangsu Province Hospital

πŸ‡¨πŸ‡³

Nanjing, Jiangsu, China

The First Affiliated Hospital of Nanchang University

πŸ‡¨πŸ‡³

Nanchang, Jiangxi, China

The Second Hospital of Jilin University

πŸ‡¨πŸ‡³

Changchun, Jilin, China

Renji Hospital, Shanghai Jiaotong University

πŸ‡¨πŸ‡³

Shanghai, Shanghai, China

Affiliated Hospital of Qinghai University

πŸ‡¨πŸ‡³

Xining, Qinghai, China

The First Affiliated Hospital of Xi'an Jiaotong University

πŸ‡¨πŸ‡³

Xi'an, Shanxi, China

Ruijing Hospital, Shanghai Jiaotong University

πŸ‡¨πŸ‡³

Shanghai, Shanghai, China

The First Affiliated Hospital of Xinjiang Medical University

πŸ‡¨πŸ‡³

Ürümqi, Xinjiang, China

Sir Run Run Shaw Hospital, Zhejiang University School of Medicince

πŸ‡¨πŸ‡³

Hangzhou, Zhejiang, China

Hangzhou First People's Hospital

πŸ‡¨πŸ‡³

Hangzhou, Zhejiang, China

Fujian Cancer Hospital

πŸ‡¨πŸ‡³

Fuzhou, Fujian, China

Β© Copyright 2025. All Rights Reserved by MedPath